Uses, Side Effects, Price ofEUREPA V 1/0.2mg Tablet 10's:

EUREPA V 1/0.2MG TABLET is a mixture of Repaglinide and Voglibose which belongs to the institution of drugs known as Anti-diabetic agents. EUREPA V 1/0.2MG TABLET is used as an adjunct (to weight loss program and exercise) to deal with kind 2 Diabetes Mellitus in sufferers to assist manipulate blood sugar stage.

EUREPA V 1/0.2MG TABLET isn't endorsed to be used in sufferers allergic to Repaglinide and/or Voglibose. It is likewise now no longer endorsed to be used in sufferers with kind 1 diabetes, diabetic ketoacidosis (severe trouble of diabetes), extreme infection (before/after an operation), gastrointestinal obstruction (bowel obstruction) and/or slight to extreme liver disease.

Before taking EUREPA V 1/0.2MG TABLET, tell your physician in case you are scheduled for a main surgical operation and/or have extreme illness, fever, trauma, infection, persistent intestinal disease, kidney problems (together with mild/slight/extreme renal impairment).

USEEUREPA V 1/0.2mg Tablet 10's

• Adjunct to weight loss plan and workout to deal with kind-2 diabetes mellitus in affected individuals

SIDE EFFECTS OFEUREPA V 1/0.2mg Tablet 10's:

Most facet consequences now no longer require any clinical interest and disappear as your frame adjusts to the medicine. Consult your physician in the event that they persist or if you’re involved approximately them

• Signs of hypoglycaemia (low blood sugar) together with fast coronary heart rate, shaking, sweating
• Abdominal ache/discomfort, diarrhoea
• Signs of gastritis (irritation of stomach) together with top stomach ache, nausea, vomiting
• Swelling of face/arms/legs
• Headache, fever
• Sore throat

Caution :

• Keep out of reach of children.
• Keep away from direct sunlight.

FAQs:

Q1.What is EUREPA V 1/0.2MG TABLET used for? EUREPA V 1/0.2MG TABLET is a mixture of Repaglinide and Voglibose which belongs to the institution of drugs known as Anti-diabetic agents. It is typically used as an adjunct (to weight loss program and exercise) to deal with kind 2 Diabetes Mellitus in sufferers to assist manipulate blood sugar stage.

Q2.What are the aspect consequences of EUREPA V 1/0.2MG TABLET? The maximum not unusualplace aspect consequences of taking EUREPA V 1/0.2MG TABLET are hypoglycaemia (low blood sugar), belly ache/discomfort, diarrhoea, headache, fever, muscle ache and/or tenderness. Consult and tell your physician if any of those signs worsen.

Q3. How EUREPA V 1/0.2MG TABLET works? EUREPA V 1/0.2MG TABLET is a mixture of Repaglinide and Voglibose wherein Repaglinide will increase the quantity of insulin launched via way of means of the pancreas and Voglibose inhibits the motion of α-glucosidase (an intestinal enzyme accountable for breaking down complicated sugars into easy sugars) which ends up in reducing the blood glucose stage and consequently treating kind-2 diabetes mellitus in affected individuals.